Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • MAVERIX ADDS JIM BRISTOW TO SCIENTIFIC ADVISORY BOARD

    Sep 30, 2014, 00:00 AM by Michael Croft
    SAN MATEO, CA - Sep 30, 2014 - Maverix Biomics Inc., a leading genomic analysis software company, today announced that Jim Bristow, M
    Full story
  • Rho Highlights Risk-Based Monitoring and History of Success at 6th Annual OCT New England Conference

    Sep 30, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Sep 30, 2014 -   WHAT:  Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services, including risk-based monitoring (RBM) strategies, at the Outsourcing in Clinical Trials (OCT) New England Conference taking place October 7-8 in Boston, Massachusetts
    Full story
  • New, Larger Facility for Transcriptic Robotics Lab

    Sep 29, 2014, 08:10 AM by Michael Croft
    Bio-IT World News Brief | Transcriptic, the programmable lab-for-hire, has moved to a new, 10,000-square foot location as it adds more instruments and "work cells" where experiments are conducted.
    Full story
  • Biosimilars Set to Revolutionize Global Drug Development Industry with More Than 700 Therapies in Pipelines

    Sep 29, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 29, 2014 - The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the release of Biosimilars: A Global Perspective of a New Market – Opportunities, Threats and Critical Strategies 2014
    Full story
  • PHASE 2 TRIAL OF BINIMETINIB IN NRAS MELANOMA SHOWS PROMISING CLINICAL ACTIVITY

    Sep 29, 2014, 00:00 AM by Michael Croft
    BOULDER, CO, UNITED STATES - Sep 29, 2014 -  Final results from a Phase 2 trial of binimetinib in patients with advanced NRAS mutant melanoma were presented today at the European Society for Medical Oncology (ESMO) Annual Meeting in Madrid, Spain
    Full story
  • CRISPR Knockin Mice Enable Rapid Gene Editing

    Sep 26, 2014, 08:55 AM by Michael Croft
    Bio-IT World News Brief | Researchers at the Broad Institute of MIT and Harvard have created a line of mice whose cells naturally express the Cas9 protein used in CRISPR gene editing, which can be used for virtually any gene knockdown experiment.
    Full story
  • Thomson Reuters Predicts 2014 Nobel Laureates, Researchers Forecast for Nobel Recognition

    Sep 26, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Sep 26, 2014 - The Intellectual Property &  Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, announced its 2014 “Nobel-class” Citation Laureates  today
    Full story
  • GeneHub Pulls Its Kickstarter Project to Sequence Whole Genomes for the Masses

    Sep 25, 2014, 13:35 PM by Michael Croft
    Bio-IT World News Brief | Just two days after launching a Kickstarter campaign to start the world's first brokerage service for personal whole genome sequencing, GeneHub has pulled the plug.
    Full story
  • Illumina at EmTech

    Sep 25, 2014, 09:35 AM by Michael Croft
    Bio-IT World News Brief | Francis de Souza, president of gene sequencing company Illumina, spoke at the EmTech conference in Cambridge this week about his company's pivot to clinical use, and a growing market for whole genome sequencing that he says will produce 228,000 whole human genomes in 2014 alone.
    Full story
  • Screening Compound Libraries from Otava

    Sep 25, 2014, 00:00 AM by Michael Croft
    TORONTO, CANADA - Sep 25, 2014 - Chemical libraries for a long time have been a cornerstone in the search for new pharmaceutical compounds
    Full story
  • GeneHub Wants to Sell Whole Genomes Direct to Consumer

    Sep 24, 2014, 08:55 AM by Michael Croft
    Bio-IT World News Brief | San Francisco-based GeneHub has plans to become the first company selling whole genome sequences to all comers, and launched a Kickstarter campaign this week to raise the funds it needs to get started.
    Full story
  • Cambridge Healthtech Institute Announces the Acquisition of OpenHelix

    Sep 24, 2014, 00:00 AM by Michael Croft
    NEEDHAM, MA - Sep 24, 2014 - Cambridge Healthtech Institute Announces the Acquisition of OpenHelixProvider of online and onsite bioinformatics training to join Cambridge Healthtech Institute as division of Bio-IT World Cambridge Healthtech Institute (CHI) announced the purchase of Washington-based OpenHelix, the provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web
    Full story
  • Outstanding Dotmatics UGM Draws Record Attendance from across the Globe

    Sep 24, 2014, 00:00 AM by Michael Croft
    BISHOP'S STORTFORD, UK - Sep 24, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services, announced today that this year’s European User Group Meeting (EUGM) held at Down Hall Country House Hotel, Hertfordshire was the largest and most successful to date
    Full story
  • Big Changes for Molecular Diagnostics as FDA Moves on Lab Developed Tests

    Sep 23, 2014, 12:15 PM by Michael Croft
    Clinical Informatics News | As the FDA extends its oversight to tests designed and performed in a single laboratory, diagnostic companies are celebrating a more even playing field. But hospital and academic labs worry that the high price tag of FDA review will stifle their in-house tests without protecting patients.
    Full story
  • Technological innovations are driving the shale oil production in US

    Sep 23, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Sep 23, 2014 - Mumbai, India - September 15, 2014 - Various technological advancements and innovations have led to an increase in the extraction of shale oil from oil reserves in the US
    Full story
  • 15 Biotechs to Watch

    Sep 22, 2014, 12:55 PM by Michael Croft
    Fierce Biotech | Fierce Biotech has unveiled its hotly-anticipated Fierce 15, an annual list of biotech companies showing special promise in delivering transformative new therapies.
    Full story
  • RainDance Technologies Names Fritz Eibel as Senior Vice President of Strategic Marketing

    Sep 22, 2014, 00:00 AM by Michael Croft
    BILLERICA, MA - Sep 22, 2014 -  RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Frederick (Fritz) L
    Full story
  • Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule

    Sep 19, 2014, 00:00 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - Sep 19, 2014 - For Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, partnering is an integral part of its business strategy
    Full story
  • The Immunotherapy Challenge: Moving from Preclinical Research to Clinical Practice

    Sep 18, 2014, 08:35 AM by Michael Croft
    Bio-IT World | Contributed Commentary | As personalized medicine opens up new possibilities in cancer immunotherapy, quantified image analysis is a promising route to discovering biomarkers that can meaningfully stratify patients for treatment.
    Full story
  • The Latest Scoop on the MinION Portable Sequencer

    Sep 17, 2014, 09:30 AM by Michael Croft
    MIT Technology Review | Oxford Nanopore, and the early access users of its MinION nanopore sequencer, share details about the device's accuracy, read length, applications, and a forthcoming high throughput instrument.
    Full story
  • «
  • 391
  • 392
  • 393
  • 394
  • 395 (current)
  • 396
  • 397
  • 398
  • 399
  • 400
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy